{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "10926562", "DateCompleted": {"Year": "2000", "Month": "08", "Day": "31"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1040-0605", "JournalIssue": {"Volume": "279", "Issue": "2", "PubDate": {"Year": "2000", "Month": "Aug"}}, "Title": "American journal of physiology. Lung cellular and molecular physiology", "ISOAbbreviation": "Am J Physiol Lung Cell Mol Physiol"}, "ArticleTitle": "Transgenic overexpression of beta(2)-adrenergic receptors in airway epithelial cells decreases bronchoconstriction.", "Pagination": {"StartPage": "L379", "EndPage": "L389", "MedlinePgn": "L379-89"}, "Abstract": {"AbstractText": ["Airway epithelial cells express beta(2)-adrenergic receptors (beta(2)-ARs), but their role in regulating airway responsiveness is unclear. With the Clara cell secretory protein (CCSP) promoter, we targeted expression of beta(2)-ARs to airway epithelium of transgenic (CCSP-beta(2)-AR) mice, thereby mimicking agonist activation of receptors only in these cells. In situ hybridization confirmed that transgene expression was confined to airway epithelium, and autoradiography showed that beta(2)-AR density in CCSP-beta(2)-AR mice was approximately twofold that of nontransgenic (NTG) mice. Airway responsiveness measured by whole body plethysmography showed that the methacholine dose required to increase enhanced pause to 200% of baseline (ED(200)) was greater for CCSP-beta(2)-AR than for NTG mice (345 +/- 34 vs. 157 +/- 14 mg/ml; P < 0.01). CCSP-beta(2)-AR mice were also less responsive to ozone (0.75 ppm for 4 h) because enhanced pause in NTG mice acutely increased to 77% over baseline (P < 0.05) but remained unchanged in the CCSP-beta(2)-AR mice. Although both groups were hyperreactive to methacholine 6 h after ozone exposure, the ED(200) for ozone-exposed CCSP-beta(2)-AR mice was equivalent to that for unexposed NTG mice. These findings show that epithelial cell beta(2)-ARs regulate airway responsiveness in vivo and that the bronchodilating effect of beta-agonists results from activation of receptors on both epithelial and smooth muscle cells."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267, USA."}], "Identifier": [], "LastName": "McGraw", "ForeName": "D W", "Initials": "DW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Forbes", "ForeName": "S L", "Initials": "SL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mak", "ForeName": "J C", "Initials": "JC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Witte", "ForeName": "D P", "Initials": "DP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Carrigan", "ForeName": "P E", "Initials": "PE"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Leikauf", "ForeName": "G D", "Initials": "GD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liggett", "ForeName": "S B", "Initials": "SB"}], "GrantList": [{"GrantID": "HL-41496", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-45967", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-54829", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Physiol Lung Cell Mol Physiol", "NlmUniqueID": "100901229", "ISSNLinking": "1040-0605"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adrenergic beta-Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Adrenergic beta-Antagonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Muscarinic Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Adrenergic, beta-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Recombinant Fusion Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "SCGB1A1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Scgb1a1 protein, mouse"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9060-09-7", "NameOfSubstance": "Uteroglobin"}, {"RegistryNumber": "K7Q1JQR04M", "NameOfSubstance": "Dinoprostone"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Adrenergic beta-Agonists"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Adrenergic beta-Antagonists"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["genetics"], "DescriptorName": "Animals, Genetically Modified"}, {"QualifierName": ["chemistry"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["drug effects", "genetics"], "DescriptorName": "Bronchoconstriction"}, {"QualifierName": ["analysis"], "DescriptorName": "Dinoprostone"}, {"QualifierName": [], "DescriptorName": "Gene Expression"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["cytology", "metabolism"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Transgenic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Muscarinic Agonists"}, {"QualifierName": ["analysis"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Plethysmography, Whole Body"}, {"QualifierName": [], "DescriptorName": "Promoter Regions, Genetic"}, {"QualifierName": ["genetics"], "DescriptorName": "Proteins"}, {"QualifierName": ["biosynthesis"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "Receptors, Adrenergic, beta-2"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "Recombinant Fusion Proteins"}, {"QualifierName": ["cytology", "metabolism"], "DescriptorName": "Respiratory Mucosa"}, {"QualifierName": ["genetics"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["genetics"], "DescriptorName": "Transgenes"}, {"QualifierName": [], "DescriptorName": "Uteroglobin"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "8", "Day": "5", "Hour": "11", "Minute": "0"}, {"Year": "2000", "Month": "9", "Day": "2", "Hour": "11", "Minute": "1"}, {"Year": "2000", "Month": "8", "Day": "5", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10926562", "10.1152/ajplung.2000.279.2.L379"]}}], "PubmedBookArticle": []}